Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01638676
Title A Phase I/II Trial of Vemurafenib and Metformin to Melanoma Patients
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors James Graham Brown Cancer Center
Indications

melanoma

Therapies

Metformin + Vemurafenib

Age Groups: adult
Covered Countries USA

Additional content available in CKB BOOST